ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 4ο | Page 72

ΙSSN: 2623- 3673
Φεβρουάριος, 2019
Ψυχολογία :έρευνα & εφαρμογές
92. Tschoner A, Engl J, Laimer M, Kaser S, Rettenbacher M, Fleischhacker W,
Patsch J, Ebenbichler C.Int J Clin Pract. 2007 Aug;61(8):1356-70. Metabolic
side effects of antipsychotic medication.
93. Madhubhashinee Dayabandara, Raveen Hanwella, Suhashini Ratnatunga,
Sudarshi Seneviratne, Chathurie Suraweera, and Varuni A de Silva
Neuropsychiatr Dis Treat. 2017; 13: 2231–2241. Antipsychotic-associated
weight gain: management strategies and impact on treatment adherence
Likelihood of weight gain with antipsychotics.
94. Γρηγόριος Ν. Καρακατσούλης. H ψυχιατρική φαρμακογενετική ως κριτήριο
εξατομικευμένης φαρμακοθεραπευτικής επιλογής, περ. "ΨΥΧΟΛΟΓΙΑ έρευνα
και εφαρμογές" Γ’ Τεύχος, Αυγ. 2018.
95. Marketa Marvanova (2013) Mental Health Clinician: September 2013, Vol.
3, No. 3, pp. 154-161.Strategies for prevention and management of second
generation antipsychotic-induced metabolic side effects.
96. Corfas G, Roy K, Buxbaum J. Nat Neurosci. 2004 Jun;7(6):575-80.
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.
97. Roja Motaghedi Timothy E. McGraw Obesity The CB1 Endocannabinoid
System Modulates Adipocyte Insulin Sensitivity
98. J Biol Chem. 2014 Mar 14; 289(11): 7547–7557. Sterol Regulatory Element-
binding Protein (SREBP) Cleavage Regulates Golgi-to-Endoplasmic Reticulum
Recycling of SREBP Cleavage-activating Protein (SCAP)
99. Joyce A. Generali, RPh, MS, Dennis J. Cada Hosp Pharm. 2013 Oct; 48(9):
734–777. Metformin: Prevention and Treatment of Antipsychotic-Induced
Weight Gain,
100.Αntipsychotic drug treatment guidelines for the management of weight gain,
ver 1 dec 16
101. Gain Joyce A. Generali, Dennis J. Cada, Hosp Pharm. 2014 Apr; 49(4):
345–347. Topiramate: Antipsychotic-Induced Weight